Latest Operational Investments News

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

RocketBoots has secured a significant A$3.3 million activation contract with a tier-one multinational retailer and reported over 50% growth in its early sales pipeline, supported by a strong cash position of A$5 million.

Connexion Mobility reported a record $3 million quarterly revenue, boosted by exclusive software deployment for GM Canada’s Enhanced Exposure Program, while net profit before tax fell 31% due to higher expenses.

Bendigo and Adelaide Bank has announced new long-term partnerships with Infosys and Genpact to enhance technology and operational efficiency, alongside a 7.6% increase in cash earnings for the third quarter of 2026.

H3 Energy’s latest technical review reveals promising signs for commercial gas flow at the Warro Field, setting the stage for a targeted appraisal campaign.

Saferoads Holdings Limited has reported a return to profitability with a $504k half-year net profit, driven by strong product sales following the sale of its Road Safety Rentals business. The company also announced a fully franked interim dividend of 0.5 cents per share.

Vault Minerals has delivered a robust half-year result with a 44% jump in EBITDA and declared its first-ever dividend, signalling confidence in its growth and cash flow outlook.

Baby Bunting has reported a robust first half FY26 performance, driven by strong sales growth and a record gross margin, while maintaining its full-year profit guidance amid ongoing store refurbishments.

H3 Energy’s latest technical evaluation of the Warro 3 well reveals 11 promising dry gas zones, setting the stage for a targeted horizontal appraisal well to unlock commercial gas flow.

Freehill Mining Limited reported a robust 46% increase in quarterly sales, driven by strong demand at its Islon aggregate site and steady contributions from Yerbas Buenas. Meanwhile, the company advances promising copper and gold project assessments.

CONNEQT Health has reported a remarkable surge in Pulse device sales, exceeding 200% growth quarter-on-quarter, while advancing its transition to a recurring revenue model through enterprise contracts and consumer subscriptions.

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.